Pnc Financial Services Group, Inc. Bio Techne Corp Transaction History

Pnc Financial Services Group, Inc.

  • $148 Billion
  • Q4 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 92,910 shares of TECH stock, worth $6.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
92,910
Previous 90,342 2.84%
Holding current value
$6.13 Million
Previous $7.22 Million 7.3%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025
BUY
$66.37 - $78.17 $170,438 - $200,740
2,568 Added 2.84%
92,910 $6.69 Million
Q3 2024

Nov 08, 2024
BUY
$70.96 - $82.35 $56,980 - $66,127
803 Added 0.9%
90,342 $7.22 Million
Q2 2024

Aug 09, 2024
SELL
$62.12 - $84.15 $3.38 Million - $4.58 Million
-54,457 Reduced 37.82%
89,539 $6.42 Million
Q1 2024

May 10, 2024
SELL
$65.98 - $77.09 $47,109 - $55,042
-714 Reduced 0.49%
143,996 $10.1 Million
Q4 2023

Feb 09, 2024
BUY
$52.83 - $78.22 $604,903 - $895,619
11,450 Added 8.59%
144,710 $11.2 Million
Q3 2023

Nov 13, 2023
SELL
$67.52 - $89.42 $44,090 - $58,391
-653 Reduced 0.49%
133,260 $9.07 Million
Q2 2023

Aug 11, 2023
BUY
$73.76 - $85.98 $1.02 Million - $1.19 Million
13,806 Added 11.49%
133,913 $10.9 Million
Q1 2023

May 15, 2023
BUY
$71.62 - $86.62 $88,737 - $107,322
1,239 Added 1.04%
120,107 $8.91 Million
Q4 2022

Feb 10, 2023
BUY
$80.67 - $352.29 $7.18 Million - $31.3 Million
88,951 Added 297.33%
118,868 $9.85 Million
Q3 2022

Nov 10, 2022
SELL
$282.54 - $391.85 $4,803 - $6,661
-17 Reduced 0.06%
29,917 $8.5 Million
Q2 2022

Aug 12, 2022
BUY
$322.67 - $449.65 $45,496 - $63,400
141 Added 0.47%
29,934 $10.4 Million
Q1 2022

May 12, 2022
SELL
$353.85 - $487.79 $133,755 - $184,384
-378 Reduced 1.25%
29,793 $12.9 Million
Q4 2021

Feb 11, 2022
BUY
$456.15 - $525.06 $76,177 - $87,685
167 Added 0.56%
30,171 $15.6 Million
Q3 2021

Nov 05, 2021
SELL
$444.87 - $538.88 $748,271 - $906,396
-1,682 Reduced 5.31%
30,004 $14.5 Million
Q2 2021

Aug 06, 2021
SELL
$387.35 - $450.26 $129,762 - $150,837
-335 Reduced 1.05%
31,686 $14.3 Million
Q1 2021

May 07, 2021
SELL
$314.62 - $411.0 $4.21 Million - $5.5 Million
-13,391 Reduced 29.49%
32,021 $12.2 Million
Q4 2020

Feb 12, 2021
BUY
$246.9 - $321.87 $50,120 - $65,339
203 Added 0.45%
45,412 $14.4 Million
Q3 2020

Nov 06, 2020
SELL
$232.22 - $282.96 $103,337 - $125,917
-445 Reduced 0.97%
45,209 $11.2 Million
Q2 2020

Aug 07, 2020
SELL
$185.43 - $279.56 $580,025 - $874,463
-3,128 Reduced 6.41%
45,654 $12.1 Million
Q1 2020

May 08, 2020
SELL
$161.17 - $221.51 $218,868 - $300,810
-1,358 Reduced 2.71%
48,782 $9.25 Million
Q4 2019

Feb 07, 2020
SELL
$189.68 - $222.09 $45,333 - $53,079
-239 Reduced 0.47%
50,140 $11 Million
Q3 2019

Nov 08, 2019
BUY
$183.56 - $216.72 $695,508 - $821,152
3,789 Added 8.13%
50,379 $9.86 Million
Q2 2019

Aug 09, 2019
SELL
$188.72 - $215.43 $88,132 - $100,605
-467 Reduced 0.99%
46,590 $0
Q1 2019

May 10, 2019
BUY
$136.09 - $200.44 $5,307 - $7,817
39 Added 0.08%
47,057 $0
Q4 2018

Feb 08, 2019
SELL
$132.75 - $203.8 $82,039 - $125,948
-618 Reduced 1.3%
47,018 $6.8 Million
Q3 2018

Nov 09, 2018
SELL
$147.44 - $204.11 $210,102 - $290,856
-1,425 Reduced 2.9%
47,636 $0
Q2 2018

Aug 10, 2018
SELL
$144.9 - $165.58 $172,431 - $197,040
-1,190 Reduced 2.37%
49,061 $0
Q1 2018

May 11, 2018
SELL
$131.46 - $151.04 $124,755 - $143,336
-949 Reduced 1.85%
50,251 $0
Q4 2017

Feb 09, 2018
SELL
$121.17 - $134.75 $529,149 - $588,453
-4,367 Reduced 7.86%
51,200 $0
Q3 2017

Nov 13, 2017
BUY
$113.59 - $123.78 $6.31 Million - $6.88 Million
55,567
55,567 $0

Others Institutions Holding TECH

# of Institutions
614
Shares Held
156M
Call Options Held
161K
Put Options Held
12.7K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.59B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email